Stereotactic body radiotherapy (SBRT) as a treatment for localized prostate cancer: a retrospective analysis
SBRT for localized prostate cancer has favorable oncological outcomes with a low incidence of Grade 2 or higher toxicity. The results of this study are consistent with findings from prospective trials, suggesting that SBRT is an effective treatment modality. Trial registration Retrospectively registered.
Authors
- Tibaut Debacker
- Carole Mercier (ORCID: https://orcid.org/0000-0002-0427-8371)
- Piet R. Dirix (ORCID: https://orcid.org/0000-0002-1278-1903)
- Piet Ost (ORCID: https://orcid.org/0000-0002-2203-4848)
- Geert De Kerf
- Bart De Troyer
- Thomas H. Adams (ORCID: https://orcid.org/0000-0003-2961-3268)
- Marc Claessens
- Bruno De Cooman
- Guy Lamberts
Institutions
- Vrije Universiteit Brussel (BE)
- AZ Klina (BE)
- GZA Ziekenhuizen Campus Sint-Augustinus (BE)
- ZNA Middelheim Hospital (BE)
- Province of Antwerp (BE)
- Vlaamse Vereniging voor Obstetrie en Gynaecolo (BE)
- Iridium Kankernetwerk (BE)
Publication Details
- Journal
- Radiation Oncology
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1186/s13014-025-02598-8
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52